Erratum: Human prefoldin inhibits amyloid-β (Aβ) fibrillation and contributes to formation of nontoxic Aβ aggregates (Biochemistry (2013) 52:20 (3532-3542) DOI: 10.1021/bi301705c);Human prefoldin inhibits amyloid-β (Aβ) fibrillation and contributes to formation of nontoxic Aβ aggregates

Biochemistry

Volumn 52, Issue 20, 2013, Pages 3532-3542

  Sörgjerd, Karin Margareta ^a   Zako, Tamotsu ^a   Sakono, Masafumi ^a   Stirling, Peter C ^b   Leroux, Michel R ^b   Saito, Takashi ^c   Nilsson, Per ^c   Sekimoto, Misaki ^c   Saido, Takaomi C ^c   Maeda, Mizuo ^a  

^a RIKEN   (Japan)

^b SIMON FRASER UNIVERSITY   (Canada)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEINS; MAMMALS; NEURODEGENERATIVE DISEASES; PROTEINS;

ALZHEIMER'S DISEASE; CELL VIABILITY MEASUREMENT; CORTICAL NEURONS; IMMUNOHISTOCHEMISTRY; MISFOLDED PROTEINS; MOLECULAR CHAPERONES; PHEOCHROMOCYTOMA; WESTERN BLOTTING;

OLIGOMERS;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMYLOID BETA PROTEIN[1-42]; CHAPERONE; OLIGOMER; PREFOLDIN; RECOMBINANT PROTEIN; THIOFLAVINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL ASSAY; CELL VIABILITY; CONTROLLED STUDY; DISEASE MODEL; EMBRYO CELL; FIBER; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FIBRILLATION; PROTEIN MODIFICATION; RAT; UPREGULATION; WESTERN BLOTTING;

EID: 84878244836     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi5005415     Document Type: Erratum

References (71)

1. Selkoe, D. J. (2004) Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases Nat. Cell Biol. 6, 1054-1061
2. Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X. D., McKay, D. M., Tintner, R., and Frangione, B. 1992, Production of the Alzheimer amyloid β protein by normal proteolytic processing Science 258, 126-129
3. Selkoe, D. J. (1998) The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease Trends Cell Biol. 8, 447-453
4. Caughey, B. and Lansbury, P. T. (2003) Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders Annu. Rev. Neurosci. 26, 267-298
5. Chiti, F. and Dobson, C. M. (2006) Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 75, 333-366
6. Ferreira, S. T., Vieira, M. N., and De Felice, F. G. (2007) Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases IUBMB Life 59, 332-345
7. Glabe, C. G. (2008) Structural classification of toxic amyloid oligomers J. Biol. Chem. 283, 29639-29643
8. Haass, C. and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid β-peptide Nat. Rev. Mol. Cell Biol. 8, 101-112
9. Laferla, F. M., Green, K. N., and Oddo, S. (2007) Intracellular amyloid-β in Alzheimer's disease Nat. Rev. Neurosci. 8, 499-509
10. Roychaudhuri, R., Yang, M., Hoshi, M. M., and Teplow, D. B. (2009) Amyloid β-protein assembly and Alzheimer disease J. Biol. Chem. 284, 4749-4753
11. Sakono, M. and Zako, T. (2010) Amyloid oligomers: Formation and toxicity of Aβ oligomers FEBS J. 277, 1348-1358
12. Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., and Selkoe, D. J. (1999) Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons J. Neurosci. 19, 8876-8884
13. Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., Finch, C. E., Krafft, G. A., and Klein, W. L. (2003) Self-assembly of Aβ(1-42) into globular neurotoxins Biochemistry 42, 12749-12760
14. Yamamoto, N., Matsubara, E., Maeda, S., Minagawa, H., Takashima, A., Maruyama, W., Michikawa, M., and Yanagisawa, K. (2007) A ganglioside-induced toxic soluble Aβ assembly. Its enhanced formation from Aβ bearing the Arctic mutation J. Biol. Chem. 282, 2646-2655
15. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453
16. Klein, W. L. (2002) Aβ toxicity in Alzheimer's disease: Globular oligomers (ADDLs) as new vaccine and drug targets Neurochem. Int. 41, 345-352
17. Hoshi, M., Sato, M., Matsumoto, S., Noguchi, A., Yasutake, K., Yoshida, N., and Sato, K. (2003) Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β Proc. Natl. Acad. Sci. U.S.A. 100, 6370-6375
18. Takamura, A., Okamoto, Y., Kawarabayashi, T., Yokoseki, T., Shibata, M., Mouri, A., Nabeshima, T., Sun, H., Abe, K., Urisu, T., Yamamoto, N., Shoji, M., Yanagisawa, K., Michikawa, M., and Matsubara, E. (2011) Extracellular and intraneuronal HMW-AβOs represent a molecular basis of memory loss in Alzheimer's disease model mouse Mol. Neurodegener. 6, 20
19. O'Nullain, B. 2010, Amyloid β-Protein Dimers Rapidly Form Stable Synaptotoxic Protofibrils J. Neurosci. 14411-14419
20. Uversky, V. N. (2010) Mysterious oligomerization of the amyloidogenic proteins FEBS J. 277, 2940-2953
21. Bukau, B., Weissman, J., and Horwich, A. (2006) Molecular chaperones and protein quality control Cell 125, 443-451
22. Hartl, F. U. and Hayer-Hartl, M. (2002) Molecular chaperones in the cytosol: From nascent chain to folded protein Science 295, 1852-1858
23. Stirling, P. C., Bakhoum, S. F., Feigl, A. B., and Leroux, M. R. (2006) Convergent evolution of clamp-like binding sites in diverse chaperones Nat. Struct. Mol. Biol. 13, 865-870
24. Walter, S. and Buchner, J. (2002) Molecular chaperones: Cellular machines for protein folding Angew. Chem., Int. Ed. 41, 1098-1113
25. Ali, Y. O., Kitay, B. M., and Zhai, R. G. (2011) Dealing with misfolded proteins: Examining the neuroprotective role of molecular chaperones in neurodegeneration Molecules 15, 6859-6887
26. Muchowski, P. J. and Wacker, J. L. (2005) Modulation of neurodegeneration by molecular chaperones Nat. Rev. Neurosci. 6, 11-22
27. Dehle, F. C., Ecroyd, H., Musgrave, I. F., and Carver, J. A. (2010) αB-Crystallin inhibits the cell toxicity associated with amyloid fibril formation by κ-casein and the amyloid-β peptide Cell Stress Chaperones 15, 1013-1026
28. King, M., Nafar, F., Clarke, J., and Mearow, K. (2009) The small heat shock protein Hsp27 protects cortical neurons against the toxic effects of β-amyloid peptide J. Neurosci. Res. 87, 3161-3175
29. Ojha, J., Masilamoni, G., Dunlap, D., Udoff, R. A., and Cashikar, A. G. (2011) Sequestration of Toxic Oligomers by HspB1 as a Cytoprotective Mechanism Mol. Cell. Biol. 31, 3146-3157
30. Vainberg, I. E., Lewis, S. A., Rommelaere, H., Ampe, C., Vandekerckhove, J., Klein, H. L., and Cowan, N. J. (1998) Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin Cell 93, 863-873
31. Siegers, K., Waldmann, T., Leroux, M. R., Grein, K., Shevchenko, A., Schiebel, E., and Hartl, F. U. (1999) Compartmentation of protein folding in vivo: Sequestration of non-native polypeptide by the chaperonin-GimC system EMBO J. 18, 75-84
32. Leroux, M. R., Fandrich, M., Klunker, D., Siegers, K., Lupas, A. N., Brown, J. R., Schiebel, E., Dobson, C. M., and Hartl, F. U. (1999) MtGimC, a novel archaeal chaperone related to the eukaryotic chaperonin cofactor GimC/prefoldin EMBO J. 18, 6730-6743
33. Valpuesta, J. M., Martin-Benito, J., Gomez-Puertas, P., Carrascosa, J. L., and Willison, K. R. (2002) Structure and function of a protein folding machine: The eukaryotic cytosolic chaperonin CCT FEBS Lett. 529, 11-16
34. Martin-Benito, J., Gomez-Reino, J., Stirling, P. C., Lundin, V. F., Gomez-Puertas, P., Boskovic, J., Chacon, P., Fernandez, J. J., Berenguer, J., Leroux, M. R., and Valpuesta, J. M. (2007) Divergent substrate-binding mechanisms reveal an evolutionary specialization of eukaryotic prefoldin compared to its archaeal counterpart Structure 15, 101-110
35. Lundin, V. F., Stirling, P. C., Gomez-Reino, J., Mwenifumbo, J. C., Obst, J. M., Valpuesta, J. M., and Leroux, M. R. (2004) Molecular clamp mechanism of substrate binding by hydrophobic coiled-coil residues of the archaeal chaperone prefoldin Proc. Natl. Acad. Sci. U.S.A. 101, 4367-4372
36. Okochi, M., Nomura, T., Zako, T., Arakawa, T., Iizuka, R., Ueda, H., Funatsu, T., Leroux, M., and Yohda, M. (2004) Kinetics and binding sites for interaction of the prefoldin with a group II chaperonin: Contiguous non-native substrate and chaperonin binding sites in the archaeal prefoldin J. Biol. Chem. 279, 31788-31795
37. Sakono, M., Zako, T., Ueda, H., Yohda, M., and Maeda, M. (2008) Formation of highly toxic soluble amyloid β oligomers by the molecular chaperone prefoldin FEBS J. 275, 5982-5993
38. Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K. H., Mistl, C., Rothacher, S., Ledermann, B., Burki, K., Frey, P., Paganetti, P. A., Waridel, C., Calhoun, M. E., Jucker, M., Probst, A., Staufenbiel, M., and Sommer, B. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology Proc. Natl. Acad. Sci. U.S.A. 94, 13287-13292
39. Simons, C. T., Staes, A., Rommelaere, H., Ampe, C., Lewis, S. A., and Cowan, N. J. (2004) Selective contribution of eukaryotic prefoldin subunits to actin and tubulin binding J. Biol. Chem. 279, 4196-4203
40. Hama, E., Shirotani, K., Masumoto, H., Sekine-Aizawa, Y., Aizawa, H., and Saido, T. C. (2001) Clearance of extracellular and cell-associated amyloid β peptide through viral expression of neprilysin in primary neurons J. Biochem. 130, 721-726
41. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300, 486-489
42. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo Nature 416, 535-539
43. Lacor, P. N., Buniel, M. C., Furlow, P. W., Clemente, A. S., Velasco, P. T., Wood, M., Viola, K. L., and Klein, W. L. (2007) Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease J. Neurosci. 27, 796-807
44. Macario, A. J. and Conway de Macario, E. (2005) Sick chaperones, cellular stress, and disease N. Engl. J. Med. 353, 1489-1501
45. Wilhelmus, M. M., de Waal, R. M., and Verbeek, M. M. (2007) Heat shock proteins and amateur chaperones in amyloid-β accumulation and clearance in Alzheimer's disease Mol. Neurobiol. 35, 203-216
46. Willander, H., Hermansson, E., Johansson, J., and Presto, J. (2011) BRICHOS domain associated with lung fibrosis, dementia and cancer: A chaperone that prevents amyloid fibril formation? FEBS J. 278, 3893-3904
47. Magrane, J., Smith, R. C., Walsh, K., and Querfurth, H. W. (2004) Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed β-amyloid in neurons J. Neurosci. 24, 1700-1706
48. Behrends, C., Langer, C. A., Boteva, R., Bottcher, U. M., Stemp, M. J., Schaffar, G., Rao, B. V., Giese, A., Kretzschmar, H., Siegers, K., and Hartl, F. U. (2006) Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers Mol. Cell 23, 887-897
49. Kitamura, A., Kubota, H., Pack, C. G., Matsumoto, G., Hirayama, S., Takahashi, Y., Kimura, H., Kinjo, M., Morimoto, R. I., and Nagata, K. (2006) Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state Nat. Cell Biol. 8, 1163-1170
50. Tam, S., Geller, R., Spiess, C., and Frydman, J. (2006) The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions Nat. Cell Biol. 8, 1155-1162
51. Sorgjerd, K., Ghafouri, B., Jonsson, B. H., Kelly, J. W., Blond, S. Y., and Hammarstrom, P. (2006) Retention of misfolded mutant transthyretin by the chaperone BiP/GRP78 mitigates amyloidogenesis J. Mol. Biol. 356, 469-482
52. Oda, T., Wals, P., Osterburg, H. H., Johnson, S. A., Pasinetti, G. M., Morgan, T. E., Rozovsky, I., Stine, W. B., Snyder, S. W., Holzman, T. F., Krafft, G. A., and Finch, C. E. (1995) Clusterin (apoJ) alters the aggregation of amyloid β-peptide (Aβ1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress Exp. Neurol. 136, 22-31
53. Stege, G. J., Renkawek, K., Overkamp, P. S., Verschuure, P., van Rijk, A. F., Reijnen-Aalbers, A., Boelens, W. C., Bosman, G. J., and de Jong, W. W. (1999) The molecular chaperone αB-crystallin enhances amyloid β neurotoxicity Biochem. Biophys. Res. Commun. 262, 152-156
54. Zako, T., Iizuka, R., Okochi, M., Nomura, T., Ueno, T., Tadakuma, H., Yohda, M., and Funatsu, T. (2005) Facilitated release of substrate protein from prefoldin by chaperonin FEBS Lett. 579, 3718-3724
55. Sinha, S., Lopes, D. H., Du, Z., Pang, E. S., Shanmugam, A., Lomakin, A., Talbiersky, P., Tennstaedt, A., McDaniel, K., Bakshi, R., Kuo, P. Y., Ehrmann, M., Benedek, G. B., Loo, J. A., Klarner, F. G., Schrader, T., Wang, C., and Bitan, G. (2011) Lysine-specific molecular tweezers are broad-spectrum inhibitors of assembly and toxicity of amyloid proteins J. Am. Chem. Soc. 133, 16958-16969
56. Laganowsky, A., Liu, C., Sawaya, M. R., Whitelegge, J. P., Park, J., Zhao, M., Pensalfini, A., Soriaga, A. B., Landau, M., Teng, P. K., Cascio, D., Glabe, C., and Eisenberg, D. (2012) Atomic view of a toxic amyloid small oligomer Science 335, 1228-1231
57. Ladiwala, A. R., Litt, J., Kane, R. S., Aucoin, D. S., Smith, S. O., Ranjan, S., Davis, J., Van Nostrand, W. E., and Tessier, P. M. (2012) Conformational Differences between Two Amyloid β Oligomers of Similar Size and Dissimilar Toxicity J. Biol. Chem. 287, 24765-24773
58. Noguchi, A., Matsumura, S., Dezawa, M., Tada, M., Yanazawa, M., Ito, A., Akioka, M., Kikuchi, S., Sato, M., Ideno, S., Noda, M., Fukunari, A., Muramatsu, S., Itokazu, Y., Sato, K., Takahashi, H., Teplow, D. B., Nabeshima, Y., Kakita, A., Imahori, K., and Hoshi, M. (2009) Isolation and characterization of patient-derived, toxic, high mass amyloid β-protein (Aβ) assembly from Alzheimer disease brains J. Biol. Chem. 284, 32895-32905
59. Wilcox, K. C., Lacor, P. N., Pitt, J., and Klein, W. L. (2011) Aβ oligomer-induced synapse degeneration in Alzheimer's disease Cell. Mol. Neurobiol. 31, 939-948
60. Williams, T. L. and Serpell, L. C. (2011) Membrane and surface interactions of Alzheimer's Aβ peptide: Insights into the mechanism of cytotoxicity FEBS J. 278, 3905-3917
61. Ta, H. P., Berthelot, K., Coulary-Salin, B., Desbat, B., Gean, J., Servant, L., Cullin, C., and Lecomte, S. (2011) Comparative studies of nontoxic and toxic amyloids interacting with membrane models at the air-water interface Langmuir 27, 4797-4807
62. Biancalana, M. and Koide, S. (2010) Molecular mechanism of Thioflavin-T binding to amyloid fibrils Biochim. Biophys. Acta 1804, 1405-1412
63. Stroud, J. C., Liu, C., Teng, P. K., and Eisenberg, D. (2012) Toxic fibrillar oligomers of amyloid-β have cross-β structure Proc. Natl. Acad. Sci. U.S.A. 109, 7717-7722
64. Iqbal, K., Flory, M., Khatoon, S., Soininen, H., Pirttila, T., Lehtovirta, M., Alafuzoff, I., Blennow, K., Andreasen, N., Vanmechelen, E., and Grundke-Iqbal, I. (2005) Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers Ann. Neurol. 58, 748-757
65. Blomberg, M., Jensen, M., Basun, H., Lannfelt, L., and Wahlund, L. O. (1996) Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele ε4 during 14 months follow-up Neurosci. Lett. 214, 163-166
66. Vandermeeren, M., Mercken, M., Vanmechelen, E., Six, J., van de Voorde, A., Martin, J. J., and Cras, P. (1993) Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay J. Neurochem. 61, 1828-1834
67. Almeida, C. G., Takahashi, R. H., and Gouras, G. K. (2006) β-Amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system J. Neurosci. 26, 4277-4288
68. Oh, S., Hong, H. S., Hwang, E., Sim, H. J., Lee, W., Shin, S. J., and Mook-Jung, I. (2005) Amyloid peptide attenuates the proteasome activity in neuronal cells Mech. Ageing Dev. 126, 1292-1299
69. Tseng, B. P., Green, K. N., Chan, J. L., Blurton-Jones, M., and LaFerla, F. M. (2008) Aβ inhibits the proteasome and enhances amyloid and tau accumulation Neurobiol. Aging 29, 1607-1618
70. Loring, J. F., Wen, X., Lee, J. M., Seilhamer, J., and Somogyi, R. (2001) A gene expression profile of Alzheimer's disease DNA Cell Biol. 20, 683-695
71. Broer, L., Ikram, M. A., Schuur, M., DeStefano, A. L., Bis, J. C., Liu, F., Rivadeneira, F., Uitterlinden, A. G., Beiser, A. S., Longstreth, W. T., Hofman, A., Aulchenko, Y., Seshadri, S., Fitzpatrick, A. L., Oostra, B. A., Breteler, M. M., and van Duijn, C. M. (2011) Association of HSP70 and its co-chaperones with Alzheimer's disease J. Alzheimer's Dis. 25, 93-102